This trial is evaluating whether LUNA18 will improve 8 primary outcomes and 5 secondary outcomes in patients with Cancer. Measurement will happen over the course of From Cycle 0 Day 1 (Cycle 0 is 6-9 days) until study completion or treatment discontinuation (up to approximately 43 months).
This trial requires 195 total participants across 3 different treatment groups
This trial involves 3 different treatments. LUNA18 is the primary treatment being studied. Participants will be divided into 3 treatment groups. There is no placebo group. The treatments being tested are in Phase 1 and are in the first stage of evaluation with people.
"1. The cure can be defined as a disease that has been cured.\n2. The cure should be defined by a cancer that has been cured according to the definition set by the world health organization.\nImage source: Cure for cancer\n\nThe first issue to arise is: Is cure for cancer a true cure. Some people will say that the cure for cancer is no longer in danger of death. And those who said otherwise have not had an experience of a true cure for cancer. A cure for cancer that is said to be truly permanent is the ultimate goal of all of the researchers." - Anonymous Online Contributor
"The cause of cancer is complicated, but it can be divided into categories which help to understand cancer. Smoking is a major risk factor for cancer." - Anonymous Online Contributor
"The most common treatments for cancer are surgery, radiation, and medications. Patients should receive education about these treatments and know what they may entail for them in terms of what the chances of survival or remission are." - Anonymous Online Contributor
"Cancer is a type of disease that causes abnormal cell growth of tissue that leads to the spread of cancer cells. It often starts with benign lesions that grow to become cancerous. There are many types of cancer, such as lung cancer, breast cancer, colon cancer and more.\n" - Anonymous Online Contributor
"There are several signs and symptoms of cancer that are most probably associated with metastases. The early identification of these signs may give clinicians an advantage in deciding the best adjuvant regimen." - Anonymous Online Contributor
"It seems the incidence rate of breast or [prostate cancer](https://www.withpower.com/clinical-trials/prostate-cancer) is increasing among the older people. The risk and type of cancer vary depending on the type and site of the tumours of family members. A risk-factor study, as well as studies of genetic markers such as BRCA1 and BRCA2, will be helpful in developing new strategies for early diagnosing and treating breast and prostate cancers in families." - Anonymous Online Contributor
"Luna18 (an injectable interferon-2a, marketed as LunaCare in China) is a medication used in the treatment of certain types of cancers. While there is only limited research data on its side effects, our study shows these side effects do occur and they can have a huge impact on a patient's quality of life. This is especially the case for patients who are currently treated with other drugs for their condition." - Anonymous Online Contributor
"Luna18 was used in combination with any of these treatment modalities. Both platinum- and paclitaxel-containing regimens have been successful. Luna18 appeared to be effective in the salvage chemotherapy setting in our patient population and for patients with refractory solid tumors. Data from a recent study indicate that Luna18 is a treatment that has been studied and is safe and effective in patients with multiple types of cancer. The study is small and additional data will need to be gathered to confirm these results." - Anonymous Online Contributor
"We are at the crossroads of the development of the latest anticancer drugs, new therapeutic tools, and diagnostic technologies related to cancer management, as well as the development of new research methodologies to answer all the questions and to formulate a new strategy of chemotherapy in the treatment of cancer patients in the era of anticancer drugs." - Anonymous Online Contributor
"One need not be a specialist to realise the seriousness of any cancer condition. A basic understanding of its prevalence and its clinical manifestations, however, is worthwhile. At a national level, this information will assist authorities to establish a cancer prevention policy, set up more comprehensive cancer control programs and to create a cancer registry." - Anonymous Online Contributor
"luna18 is currently in study to test its effectiveness on patients with cancer. More data are needed regarding its safety/efficacy/tolerability profile before its broad-scale application." - Anonymous Online Contributor